Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.33−0.23 (-2.18%)
Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –
Natures Sunshine Products operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Natures Sunshine Products's operating cash flow for the twelve months ending Jun 30, 2026 was $27.36M, down 4.8% year over year. For fiscal 2025 it was $35.32M, up 39.6% from the year before. Over ten years it grew 13.3% a year on average. The highest annual figure on record is $41.23M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.32M | +39.6% |
| FY2024 | Dec 31, 2024 | $25.30M | -38.6% |
| FY2023 | Dec 31, 2023 | $41.23M | +5706.5% |
| FY2022 | Dec 31, 2022 | $710.00K | -97.9% |
| FY2021 | Dec 31, 2021 | $34.61M | -8.1% |
| FY2020 | Dec 31, 2020 | $37.66M | +340.7% |
| FY2019 | Dec 31, 2019 | $8.55M | -60.9% |
| FY2018 | Dec 31, 2018 | $21.83M | +107.5% |
| FY2017 | Dec 31, 2017 | $10.52M | +208.0% |
| FY2016 | Dec 31, 2016 | $3.42M | -66.4% |
| FY2015 | Dec 31, 2015 | $10.16M | -28.3% |
| FY2014 | Dec 31, 2014 | $14.18M | -51.7% |
| FY2013 | Dec 31, 2013 | $29.38M | +10.2% |
| FY2012 | Dec 31, 2012 | $26.65M | +582.0% |
| FY2011 | Dec 31, 2011 | $3.91M | -75.8% |
| FY2010 | Dec 31, 2010 | $16.15M | +1642.2% |
| FY2009 | Dec 31, 2009 | $927.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $835.00K | -80.8% |
| Q1 FY2026 | Mar 31, 2026 | -$1.85M | -170.8% |
| Q4 FY2025 | Dec 31, 2025 | $9.90M | -18.8% |
| Q3 FY2025 | Sep 30, 2025 | $18.47M | +92.1% |
| Q2 FY2025 | Jun 30, 2025 | $4.34M | +232.6% |
| Q1 FY2025 | Mar 31, 2025 | $2.61M | +19.1% |
| Q4 FY2024 | Dec 31, 2024 | $12.18M | +26.9% |
| Q3 FY2024 | Sep 30, 2024 | $9.62M | -33.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.31M | -83.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.19M | -76.5% |
| Q4 FY2023 | Dec 31, 2023 | $9.60M | +168.4% |
| Q3 FY2023 | Sep 30, 2023 | $14.36M | +121.8% |
| Q2 FY2023 | Jun 30, 2023 | $7.94M | – |
| Q1 FY2023 | Mar 31, 2023 | $9.33M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.58M | -75.0% |
| Q3 FY2022 | Sep 30, 2022 | $6.48M | -32.3% |
| Q2 FY2022 | Jun 30, 2022 | -$1.42M | -117.8% |
| Q1 FY2022 | Mar 31, 2022 | -$7.92M | -389.7% |
| Q4 FY2021 | Dec 31, 2021 | $14.33M | +32.5% |
| Q3 FY2021 | Sep 30, 2021 | $9.57M | -23.0% |
| Q2 FY2021 | Jun 30, 2021 | $7.98M | +782.4% |
| Q1 FY2021 | Mar 31, 2021 | $2.74M | -79.8% |
| Q4 FY2020 | Dec 31, 2020 | $10.81M | +256.4% |
| Q3 FY2020 | Sep 30, 2020 | $12.43M | +86.7% |
| Q2 FY2020 | Jun 30, 2020 | $904.00K | -67.1% |
| Q1 FY2020 | Mar 31, 2020 | $13.52M | – |
| Q4 FY2019 | Dec 31, 2019 | $3.03M | -60.2% |
| Q3 FY2019 | Sep 30, 2019 | $6.66M | +39.6% |
| Q2 FY2019 | Jun 30, 2019 | $2.75M | -51.9% |
| Q1 FY2019 | Mar 31, 2019 | -$3.90M | -204.9% |
| Q4 FY2018 | Dec 31, 2018 | $7.63M | +206.6% |
| Q3 FY2018 | Sep 30, 2018 | $4.77M | -45.3% |
| Q2 FY2018 | Jun 30, 2018 | $5.72M | – |
| Q1 FY2018 | Mar 31, 2018 | $3.71M | +379.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.49M | – |
| Q3 FY2017 | Sep 30, 2017 | $8.72M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.46M | – |
| Q1 FY2017 | Mar 31, 2017 | $774.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.65M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.40M | – |
See a number that looks wrong?